<DOC>
	<DOCNO>NCT02204917</DOCNO>
	<brief_summary>In clinical trial investigator aim evaluate diagnostic feasibility safety ceVUS intravesical use OPTISON vesicoureteral reflux detection urethral imaging child .</brief_summary>
	<brief_title>CeVUS With Intravesical Administration OPTISON TM ( Trademark ) Children</brief_title>
	<detailed_description>Contrast enhance Voiding Urosonography ( ceVUS ) radiation free , highly sensitive image modality vesicoureteral reflux ( VUR ) urethral image child . It employ ultrasound technology combination ultrasound contrast agent , administer intravesically via bladder catheter . Currently , second generation ultrasound contrast agent commercially available , comprise gas-filled microbubbles . CeVUS child widely practice , primarily Europe , despite fact none commercially available ultrasound contrast agent yet approve clinical application pediatric population . In United States , limited clinical experience ceVUS child . Among currently commercially available ultrasound contrast agent , OPTISON already use research off-label clinical setting involve adult child . One in-vitro study conduct aim optimize ultrasound technical parameter dose OPTISON intravesical administration child . In clinical trial investigator aim evaluate diagnostic feasibility safety ceVUS intravesical use OPTISON vesicoureteral reflux detection urethral imaging child .</detailed_description>
	<mesh_term>Vesico-Ureteral Reflux</mesh_term>
	<criteria>Inclusion criterion : 1 . Children 218 year ( first age cohort ) . 2 . Children 018 year ( second age cohort ) . 3 . Referred CHOP performance clinically indicate VCUG examination . 4 . Parental/guardian permission ( informed consent ) appropriate , child 's assent additional performance ceVUS examination . Exclusion criterion : 1 . Hypersensitivity perflutren , blood , blood product albumin . 2 . Children require sedation VCUG ceVUS examination . 3 . Parents/guardians subject , opinion principal investigator , may noncompliant study schedule procedure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ultrasound</keyword>
	<keyword>Ultrasound Contrast Agents</keyword>
	<keyword>Optison</keyword>
	<keyword>contrast enhance Voiding Urosonography</keyword>
	<keyword>ceVUS</keyword>
	<keyword>Vesicoureteral Reflux</keyword>
	<keyword>Children</keyword>
	<keyword>Kidney</keyword>
	<keyword>Bladder</keyword>
	<keyword>Urethra</keyword>
	<keyword>Voiding Cystourethrography</keyword>
	<keyword>VCUG</keyword>
	<keyword>Safety</keyword>
	<keyword>Urinary tract</keyword>
</DOC>